Myasthenia Gravis Clinical Trials in Los Angeles, California

4 studies are recruiting for myasthenia gravis in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

    The purpose of this study is to determine the effect of nipocalimab on total serum immunoglobulin G (IgG) in pediatric participants 2 to less than (<) 18 years of age (globally) and 8 to <18 years of age (for Unites Stated (US) sites only), the safety and tolerability of treatment with nipocalimab …

    Stage
    Phase 2
    Ages
    2 to 17
    Site
    Childrens Hospital Los Angeles, Los Angeles, California
    Locations
    19 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT05265273 on ClinicalTrials.gov

  2. KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

    A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Patients with Myasthenia Gravis

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Ronald Reagan UCLA Medical Center, Los Angeles, California
    Locations
    22 in total
    Run by
    Kyverna Therapeutics

    See if you can join NCT06193889 on ClinicalTrials.gov

  3. A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

    The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravis (gMG). The purpose of the subcutaneous substudy is to evaluate how well it works in the body (pharmacodynamic [PD]) when given as an injection under…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Southern California, Los Angeles, California
    Locations
    112 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT04951622 on ClinicalTrials.gov

  4. A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

    A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia gravis (GMG). Anitocabtagene autoleucel (anito-cel) is a BCMA-directed CAR-T cell therapy.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    UCLA Medical Center, Los Angeles, California
    Locations
    13 in total
    Run by
    Arcellx, Inc.

    See if you can join NCT06626919 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.